Clinical Trials Directory

Trials / Sponsors / Vantia Ltd

Vantia Ltd

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
CompletedEfficacy Study of Fedovapagon for Nocturia in Men With Benign Prostatic Hyperplasia (BPH)
Nocturia
Phase 2 / Phase 32016-03-01
CompletedA Study in Healthy Volunteers to Assess the Effect of Fedovapagon on the QT/QTC Interval
Healthy
Phase 12015-10-01
CompletedStudy in Healthy Male Subjects to Evaluate the Effect of Itraconazole and Rifampicin on the PK of Fedovapagon
Nocturia
Phase 12015-05-01
CompletedDose Range Finding Study of Fedovapagon in Men With Nocturia
Nocturia
Phase 22012-08-01
CompletedDose Response Study of VA106483 in Males With Nocturia and Benign Prostatic Hypertrophy (BPH)
Nocturia, Benign Prostatic Hypertrophy (BPH)
Phase 12011-03-01
CompletedVA106483 Dose Response in Females
Nocturia
Phase 12010-07-01
CompletedEfficacy Study of VA106483 in Males With Nocturia.
Nocturia
Phase 22009-12-01
CompletedVA111913 Dysmenorrhoea Efficacy and Safety Proof of Concept
Primary Dysmenorrhea
Phase 22009-08-01
CompletedVA106483 Dose Response Study in Elderly Males
Nocturia
Phase 12009-06-01
CompletedVA106483 and Alpha Blocker Interaction Study in Elderly Males
Nocturia
Phase 12009-04-01
CompletedVA111913 TS: First in Human Study
Dysmenorrhea
Phase 12008-09-01
CompletedEfficacy and Safety of VA106483 in Elderly Males
Nocturia
Phase 1 / Phase 22008-08-01